Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Hormone. University of Arizona/Arizona Cancer Center, Tucson, Arizona, United States



Survival: 17.0 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
Hormone
   
Drugs:
Country: United States
   
City/State/Province: Tucson, Arizona
   
Hospital: University of Arizona/Arizona Cancer Center
   
Journal: Link
   
Date: 7/2012

Description:
Patients:
This phase 2 study involved 34 patients with peripheral T-cell lymphoma. The median patient age was 60 years and 67% were male.

Treatment:
Patients were treated with the chemotherapy agents cisplatin, etoposide, and gemcitabine, as well as the steroid hormone methylprednisolone.

Toxicities:
There was one treatment-related death due to infection. Grade 4 neutropenia and thrombocytopenia were also reported.

Results:
The median overall survival was 17 months.

Support:
This study was supported in part by Eli Lilly and Company.

Correspondence: Dr. Daruka Mahadevan; email: dmahadevan@azcc.arizona.edu

E-mail to a Friend Email Physician More Information